Testing Guides

STD Retesting After Possible Re-Exposure: How Soon Should You Test Again?

Oct 25, 2026 5 min readBy SafeSTDTest Editorial

Person reviewing a guide about STI retesting after possible re-exposure

There is no single retesting date for every STI. Learn how timing depends on the infection, test type, exposure site, symptoms, and prior treatment.

Key takeaways

There is no universal retesting schedule for every STI or test.
A test soon after exposure can provide baseline information but may be too early to detect a new infection.
HIV testing timing depends on the assay, and a possible substantial-risk exposure within 72 hours requires prompt evaluation for PEP.
Chlamydia and gonorrhea follow-up should account for the exposed anatomical site, including the throat or rectum when clinically indicated.
Retesting about three months after treatment for chlamydia, gonorrhea, or trichomoniasis is different from testing after a very recent new exposure.

If you may have been exposed to an STI again, the right time to retest depends on what infection is possible, which test is used, where the exposure occurred, how much time has passed, and whether you previously received treatment. A negative result immediately after re-exposure does not rule out every infection because some tests can be negative before the infection becomes detectable.

Possible substantial-risk HIV exposure within the past 72 hours is time-sensitive. CDC guidance says people should be evaluated rapidly for post-exposure prophylaxis (PEP), which should be started as soon as possible and no later than 72 hours when clinically appropriate. Do not wait for a routine retest before seeking evaluation.

Start with testing now when a baseline is useful

Testing soon after a possible exposure may establish whether there was evidence of infection before the new event or provide a starting point for follow-up. However, baseline testing is not the same as a conclusive test for the recent exposure. A clinician may recommend immediate testing and a later test after the applicable window period.

Tell the clinician or testing service when the exposure occurred, whether it involved vaginal, anal, or oral sex, and which body sites were involved. Chlamydia and gonorrhea testing may need to match the exposure site. A urine test alone should not be assumed to evaluate an infection acquired in the throat or rectum.

Timing by infection and test

HIV: CDC lists approximate window periods of 10–33 days for a nucleic acid test (NAT), 18–45 days for a laboratory antigen/antibody test, 18–90 days for a rapid finger-stick antigen/antibody test, and 23–90 days for an antibody test. The appropriate follow-up date depends on the actual assay. An FDA-authorized oral-fluid HIV self-test has an approximately three-month window period, so a negative result soon after exposure may not exclude infection.
Chlamydia and gonorrhea: In specified recent-exposure circumstances, CDC guidance allows repeat testing at 1–2 weeks when initial NAATs are negative and presumptive treatment was not provided. This is conditional guidance, not a universal schedule for every exposure. Testing should reflect the anatomical sites exposed.
Syphilis: Depending on the exposure and clinical circumstances, CDC guidance supports repeat serology at 4–6 weeks and 3 months. In certain re-exposure situations, repeat nontreponemal testing 2–4 weeks after evaluation may also be considered. Syphilis results require clinical interpretation rather than relying on one isolated result.
Hepatitis C: For relevant recent-exposure situations, CDC follow-up guidance uses HCV RNA testing at 3–6 weeks and final antibody testing at 4–6 months. Antibody tests can be negative during the first several weeks, and an antibody result must be distinguished from evidence of current infection.
Herpes: CDC does not recommend routine screening of people without symptoms. If genital symptoms or lesions occur, seek clinical evaluation rather than automatically adding asymptomatic herpes blood testing to a standard retesting panel.

Do not confuse new-exposure testing with three-month retesting after treatment

CDC recommends retesting approximately three months after a diagnosis of chlamydia, gonorrhea, or trichomoniasis to detect repeat infection. This recommendation addresses reinfection after treatment and is separate from deciding whether an infection from a very recent new exposure has become detectable.

For chlamydia, CDC notes that most post-treatment infections are reinfections rather than treatment failure. A three-month retest does not by itself identify when an infection was acquired, prove that treatment failed, or establish who caused a reinfection.

A practical retesting framework

1. Get prompt advice if the exposure was recent, substantial-risk, or associated with symptoms. HIV PEP decisions are time-sensitive, especially within 72 hours.
2. Consider baseline testing when recommended. Record the test type, body site tested, date of exposure, and date of the test.
3. Schedule follow-up according to the suspected infection and assay. Do not apply one date to every STI.
4. Keep treatment follow-up separate. If you previously completed treatment for chlamydia, gonorrhea, or trichomoniasis, ask about retesting at approximately three months.
5. Review special factors with a clinician. HIV PrEP or PEP use, immunosuppression, pregnancy, previous infection, and previous treatment can affect follow-up decisions.

When to seek care instead of waiting for a routine retest

If symptoms occur, seek prompt clinical care rather than waiting for a routine retest. A clinician can determine which tests or examinations are appropriate.

Contact a healthcare professional promptly if you are pregnant or could be pregnant, if the exposure involved sexual assault, or if you are concerned about HIV, hepatitis C, or another serious exposure. CDC provides specific follow-up frameworks for sexual-assault circumstances; those schedules should not be treated as a universal protocol for every consensual sexual exposure.

Questions to ask before testing again

Which infections should be considered based on the exposure?
Which anatomical sites need testing?
What test method will be used, and what is its window period?
Should I test now for a baseline and repeat later?
Does prior treatment, PrEP, PEP, pregnancy, or another health condition change the plan?

The safest answer to “When should I retest?” is test-specific and exposure-specific: test promptly when indicated, repeat at the relevant interval for the suspected infection and assay, and obtain clinical advice when symptoms, pregnancy, or a time-sensitive HIV exposure is involved.

Bottom line

STD retesting after re-exposure is not governed by one universal day. Early testing can provide baseline information, while later testing may be needed after the relevant window period. HIV timing must match the test method; chlamydia and gonorrhea follow-up may be appropriate at 1–2 weeks in specified circumstances; syphilis and hepatitis C can require later follow-up; and routine asymptomatic herpes retesting is not recommended. If the possible HIV exposure occurred within 72 hours, seek urgent evaluation for PEP rather than waiting for a test.

Frequently asked questions

Should I retest after a new possible STI exposure if my first test was negative?

Often, yes, depending on the infection, test type, exposure site, and time since exposure. An early negative result may be a baseline result rather than proof that the recent exposure did not cause infection.

How soon should I retest for chlamydia or gonorrhea?

In specified recent-exposure circumstances, CDC guidance allows repeat testing at 1–2 weeks when initial NAATs are negative and presumptive treatment was not provided. The exposed anatomical site should guide testing.

When should I retest for HIV?

It depends on the assay. CDC lists approximate window periods ranging from 10 days to 90 days across NAT, laboratory antigen/antibody, rapid finger-stick antigen/antibody, and antibody tests. Follow the test-specific guidance.

What if the possible HIV exposure happened within 72 hours?

If a possible substantial-risk HIV exposure happened within 72 hours, seek rapid medical evaluation for PEP. CDC says PEP should be started as soon as possible and no later than 72 hours when clinically appropriate.

Is three-month retesting the same as testing after re-exposure?

No. Approximately three-month retesting after chlamydia, gonorrhea, or trichomoniasis treatment is intended to detect repeat infection. It is distinct from follow-up testing after a new exposure.

Should I retest for herpes if I have no symptoms?

Routine asymptomatic herpes testing is not recommended by CDC. If you have genital symptoms or lesions, seek clinical evaluation.

Sources & references

Sources are provided for general educational purposes only. This article is not medical advice. Consult a qualified healthcare professional with any health concerns.

Ready to compare testing options?

Use our independent, educational comparisons to understand your online STD/STI testing options.

View Provider Testing Options

Affiliate link — we may earn a commission if you choose a provider through this link, at no extra cost to you. Pricing, turnaround and availability are set by the provider and can change.